SciDEX

Main

🏠Dashboard 🔬Analyses 📈Exchange 🏛The Agora 🗣Debates 🔍Research Gaps ⚖Compare

Knowledge

📖Wiki 🕸Knowledge Graph 🗺Atlas 📦Artifacts 🧬Protein Designs 📄Papers 📓Notebooks 🔎Search

System

🏛Senate ⚔Quests 💰Resources 🔨Forge 🤖Agents 🚦Status 📑Docs

Info

ℹHow it Works 🎨Pitch ⭐Showcase 📽Demo

Dashboard Analyses Exchange Agora Debates Gaps

Wiki Graph Atlas Artifacts Protein Designs Papers Search

Senate Quests Resources Forge Status

How it Works Pitch Showcase Demo

Home / Wiki / Experiment: Synaptic Mitochondrial Resilience Enhancement for Parkinson'

experiment 974 words KG: PD 2026-03-23

kind:experiment section:experiments state:published

Contents

Synaptic Mitochondrial Resilience Enhancement for Parkinson's Disease

Knowledge Graph

Related Hypotheses (30)

Conditional CRISPR Kill Switches for Aberrant Protein Cleara
Score: 0.45 Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna
Score: 0.68 Gut Microbiome Remodeling to Prevent Systemic NLRP3 Priming
Score: 0.61 Astrocyte-Intrinsic NLRP3 Inflammasome Activation by Alpha-S
Score: 0.60 Prefrontal sensory gating circuit restoration via PV interne
Score: 0.59

Circadian-Synchronized Proteostasis Enhancement
Score: 0.58 Microbial Inflammasome Priming Prevention
Score: 0.58 PARP1 Inhibition Therapy
Score: 0.58 AMPK hypersensitivity in astrocytes creates enhanced mitocho
Score: 0.57 Smartphone-Detected Motor Variability Correction
Score: 0.56 Senescent Cell Mitochondrial DNA Release
Score: 0.54 GFAP-Positive Reactive Astrocyte Subtype Delineation
Score: 0.52 Epigenetic Memory Reprogramming via CRISPRa-Mediated Chromat
Score: 0.52 Near-infrared light therapy stimulates COX4-dependent mitoch
Score: 0.51 Sleep Spindle-Synaptic Plasticity Enhancement
Score: 0.49 TREM2-mediated microglial tau clearance enhancement
Score: 0.49 Microglial Efferocytosis Enhancement via GPR32 Superagonists
Score: 0.48 Chaperone-Mediated APOE4 Refolding Enhancement
Score: 0.48 Tau-Independent Microtubule Stabilization via MAP6 Enhanceme
Score: 0.48 TFAM overexpression creates mitochondrial donor-recipient gr
Score: 0.47 Arginine Methylation Enhancement Therapy
Score: 0.46 Lysosomal Membrane Repair Enhancement
Score: 0.45 Microbial Metabolite-Mediated α-Synuclein Disaggregation
Score: 0.45 Mitochondrial Transfer Pathway Enhancement
Score: 0.44 HSP90-Tau Disaggregation Complex Enhancement
Score: 0.44 Enteric Nervous System Prion-Like Propagation Blockade
Score: 0.44 Aquaporin-4 Polarization Enhancement via TREK-1 Channel Modu
Score: 0.44 Osmotic Gradient Restoration via Selective AQP1 Enhancement
Score: 0.43 Mitochondrial-Lysosomal Contact Site Engineering
Score: 0.43 R-Loop Resolution Enhancement Therapy
Score: 0.43

Related Analyses (30)

TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived

Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived Synaptic pruning by microglia in early AD
neurodegeneration · archived Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived Circuit-level neural dynamics in neurodegeneration
neuroscience · archived Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived TREM2 agonism vs antagonism in DAM microglia
neurodegeneration · failed What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived Mitochondrial transfer between neurons and glia
neurodegeneration · archived Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed TREM2 agonism vs antagonism in DAM microglia
neurodegeneration · archived Is disrupted sleep a cause or consequence of neurodegenerati
neurodegeneration · failed Is disrupted sleep a cause or consequence of neurodegenerati
neurodegeneration · failed Immune atlas neuroinflammation analysis in neurodegeneration
Neuroinflammation · archived Cell type vulnerability in Alzheimer's Disease (SEA-AD data)
neurodegeneration · failed Cell type vulnerability in Alzheimer's Disease (SEA-AD data
neurodegeneration · archived Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · failed TREM2 Therapeutic Strategy Post-INVOKE-2
neurodegeneration · completed GBA-Synuclein Loop Therapeutics for PD
neurodegeneration · completed Gut-Brain Axis Therapeutics for AD
neurodegeneration · completed

Related Experiments (30)

AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera
validation · proposed · Score: 0.40 AAV-LRRK2 IND-Enabling Study Design
clinical · proposed · Score: 0.40 AAV Serotype Comparison for LRRK2 Knockdown in PD
validation · proposed · Score: 0.40 Alpha-Synuclein SAA Kinetics Study — Biological Staging Back
clinical · proposed · Score: 0.40 Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio
clinical · proposed · Score: 0.40

Computational Modeling of Alpha-Synuclein Propagation in PD
validation · proposed · Score: 0.40 Basic Mechanism: Membrane-Driven Alpha-Synuclein Nucleation
validation · proposed · Score: 0.40 Alpha-Synuclein Seed Amplification Assay Validation
clinical · proposed · Score: 0.40 Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation
exploratory · proposed · Score: 0.40 Antiviral Therapy Trial for Parkinson's Disease
clinical · proposed · Score: 0.40 Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson'
clinical · proposed · Score: 0.40 Axonal Transport Dysfunction Validation in Parkinson's Disea
clinical · proposed · Score: 0.40 cGAS-STING Pathway Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.40 Chaperone-Mediated Autophagy Dysfunction in PD - Experiment
clinical · proposed · Score: 0.40 Combination Therapy Sequencing in Parkinson's Disease
validation · proposed · Score: 0.40 CRISPR Gene Correction Approaches for CBS/PSP
clinical · proposed · Score: 0.40 Alpha-Synuclein Staging and Spreading in DLB — Spatial Propa
validation · proposed · Score: 0.40 DNA Damage Repair Deficiency Validation Study in Parkinson's
clinical · proposed · Score: 0.40 Mechanism: Selective Vulnerability of Dopaminergic Neurons i
validation · proposed · Score: 0.40 Endocannabinoid System Dysfunction Validation in Parkinson's
clinical · proposed · Score: 0.40 Epigenetic Dysregulation Validation in Parkinson's Disease
clinical · proposed · Score: 0.40 ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40 Exercise-BDNF-Mitophagy Biomarker Study in PD
clinical · proposed · Score: 0.40 Ferroptosis Validation in Parkinson's Disease
clinical · proposed · Score: 0.40 GLP-1 Agonist Neuroprotection Mechanism in PD
clinical · proposed · Score: 0.40 Glymphatic-Circadian Axis Enhancement Therapy for Parkinson'
clinical · proposed · Score: 0.40 Gut-Brain Axis Pathogenesis in Parkinson's Disease — Mechani
clinical · proposed · Score: 0.40 Cytochrome Therapeutics
clinical · proposed · Score: 0.40 Lipid Droplet-Lysosome Axis Therapeutic Testing in Parkinson
clinical · proposed · Score: 0.40 Gene Therapy: AAV Serotype Comparison for LRRK2 Knockdown
validation · proposed · Score: 0.40

See Also (11)

LRRK2 G2019S Transgenic Mouse Model
model · KG edge: causes Age-Sensitive Cortical Vulnerability in Parkinson's Dis
mechanism · KG edge: associated_with MCL1 Gene - Myeloid Cell Leukemia 1
gene · KG edge: implicated_in IDH1 Gene - Isocitrate Dehydrogenase 1
gene · KG edge: implicated_in eef1a1
gene · KG edge: implicated_in

DOT1L Gene
gene · KG edge: implicated_in CNTNAP4 Gene
gene · KG edge: associated_with APOB Gene
gene · KG edge: implicated_in ABCB1 (MDR1) - ATP Binding Cassette Subfamily B Member
gene · KG edge: implicated_in DNA Damage Repair Deficiency Validation Study in Parkin
experiment · KG edge: implicated_in GBA1 (Redirect)
redirect · KG edge: causes

Knowledge Graph (12 edges)

PD causes NEURODEGENERATION

PD causes DOPAMINERGIC_NEURONS

PD causes neurodegeneration

PD contributes_to synucleinopathies

PD associated_with DEPRESSION

PD associated_with T2DM

NEUROINFLAMMATION contributes_to PD

NEUROTROPHINS treats PD

AGE associated_with PD

SNCA causes PD

SciDEX — scidex.ai — Dashboard | Atlas